在新泽西州2018年限制后,制药行业向医生支付的变化
Neeraj G Patel1, Reshma Ramachandran2,3, Joseph S Ross2,3,4
1Yale School of Medicine, New Haven, CT 06510, United States.
Health affairs scholar
|January 15, 2026
概括
新泽西州的新泽西州
科学领域:
- 卫生政策 卫生政策
- 制药行业 制药行业 制药行业
- 医学经济学 医学经济学
背景情况:
- 政府和州的政策旨在监管制药行业向临床医生支付的费用.
- 新泽西州在2018年实施了每年处方医生赔偿金1万美元的上限.
- 透明度和对支付的限制试图影响处方做法.
研究的目的:
- 评估新泽西州支付限制政策的影响.
- 为了比较新泽西州和控制州 (宾夕法尼亚州) 之间的支付趋势.
- 评估收到高总薪酬的医生的变化.
主要方法:
- 准实验性设计比较新泽西州和宾夕法尼亚州.
- 在政策实施之前和之后分析处方者支付数据.
- 超过1万美元赔偿门的医生的统计比较.
主要成果:
- 与宾夕法尼亚州相比,新泽西州的医生年薪超过1万美元的比例没有显著差异.
- 该政策并没有显著改变医生高薪补偿安排的分配.
- 限制在减少总支付方面的有效性需要进一步调查.
结论:
- 与宾夕法尼亚州相比,新泽西州限制处方医生的补偿政策没有显著影响.
- 需要进一步的研究,以了解州级政策对制药行业支付的更广泛影响.
- 调查替代政策设计或执法机制可能是必要的.
相关概念视频
FDA Approved Drugs: Changes to Approved Drugs
242
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
242
Drug Products: Biologics, Biosimilars and Interchangeables
233
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
233
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
178
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
178
Pharmaceutical Equivalents
182
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
182


